(19)
(11) EP 4 319 815 A1

(12)

(43) Date of publication:
14.02.2024 Bulletin 2024/07

(21) Application number: 22785549.1

(22) Date of filing: 08.04.2022
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61K 9/00(2006.01)
C07K 16/28(2006.01)
A61K 39/00(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 9/0019; A61K 9/08; A61K 47/02; C07K 2317/31; C07K 16/2809; C07K 16/2803; C07K 2317/622; C07K 2317/75; C07K 2317/73; A61K 2039/505; A61K 2039/545; C07K 16/2818; A61K 39/395
 
C-Sets:
A61K 39/395, A61K 2300/00;
(86) International application number:
PCT/US2022/024063
(87) International publication number:
WO 2022/217082 (13.10.2022 Gazette 2022/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.04.2021 US 202163173224 P

(71) Applicant: Anji Bruno, LLC
Cambridge, MA 02142 (US)

(72) Inventor:
  • SMITH, Victoria
    Burlingame, California 94010 (US)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) DOSING OF BISPECIFIC T CELL ENGAGER